|
| |
BioPortfolio's Approved Drugs DatabaseXyzalLevocetirizine DihydrochlorideDownload PDF containing detailed information.
Press Releases About Xyzal:
|
 |
| Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzal(R) Solution and Announcement of Lawsuit by Sepracor/UCB |
24th June, 2009 |
Perrigo Company |
ALLEGAN, Mich., June 24 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that its partner Synthon Pharmaceuticals, Inc. has filed an Abbreviated New Drug Application
|
| Perrigo Acquires Exclusive Sales and Distribution Rights to Allergy Drug Levocetirizine from Synthon |
8th September, 2008 |
Perrigo Company |
ALLEGAN, Mich., Sept. 8 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq:
PRGO; TASE) announced today that it has acquired the exclusive U.S. rights to
sell and distribute Levocetirizine tablets,
|
| Barr Confirms Patent Challenge of Xyzal(R), 5mg Tablets |
31st July, 2008 |
Barr Pharmaceuticals, Inc. |
MONTVALE, N.J., July 31 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals,
Inc. (NYSE: BRL) today confirmed that its subsidiaries, Barr Laboratories,
Inc. and PLIVA-Hrvatska D.O.O., have initiated a
|
| Sanofi-aventis News |
31st July, 2008 |
sanofi-aventis |
PARIS, July 31 /PRNewswire-FirstCall/ -- Sanofi-aventis announces solid
growth in the second quarter.
Solid growth in the second quarter
-- Net sales: euro 6,689m, up 5.2% on a
|
This page has been viewed 61 times
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Xyzal across BioPortfolio, or for Xyzal Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|